Compare places

Two or three clusters, read side by side across sectors, research, companies, capital, infrastructure, government designations and UKIZ relevance. There is no score and no ranking: British clusters are different from one another, not better or worse than one another.

Choose up to three clusters

Side by side

Dimension	CambridgeEast of England	LondonGreater London	ManchesterNorth West
Sectors	Life Sciences, Semiconductors, Engineering Biology, Artificial Intelligence Supporting: Quantum Technologies, Advanced Materials, AgriTech & FoodTech, Digital Technologies	Financial Technology, Artificial Intelligence, Creative Industries, Digital Technologies Supporting: Life Sciences, Quantum Technologies, Engineering Biology, Defence & Security	Advanced Materials, Life Sciences, Digital Technologies, Creative Industries Supporting: Artificial Intelligence, Advanced Manufacturing, Financial Technology, Engineering Biology
Research	University of Cambridge Wellcome Sanger Institute MRC Laboratory of Molecular Biology	Imperial College London University College London King's College London Queen Mary University of London The Alan Turing Institute The Francis Crick Institute	The University of Manchester Manchester Metropolitan University National Graphene Institute Greater Manchester health innovation partnership
Companies	Cambridge semiconductor and processor IP cluster	Not recorded on the map.	Not recorded on the map.
Infrastructure	Babraham Research Campus Cambridge Science Park University and institute laboratories, genomics and biomedical campus facilities, and semiconductor design capability.	Digital Catapult Connected Places Catapult Cell and Gene Therapy Catapult Level39 University laboratories, teaching hospitals, data centre and compute capacity, and the densest transport network in the country.	MediaCity Advanced manufacturing Catapult capability, North West National materials and graphene facilities, teaching hospitals and clinical research capability, and a major broadcast production estate.
Capital	Specialist deep tech and life science funds, university-linked funds, and corporate partners; strong at seed, thinner at growth stage relative to demand.	London venture and growth capital ecosystem Venture, growth and public market capital at a scale unmatched elsewhere in Europe, plus corporate venture arms and international investors with UK offices.	A growing regional investor base and northern funds, with growth rounds usually led from London.
Government programmes	No place-based designation recorded.	No place-based designation recorded.	No place-based designation recorded.
What exists	Extreme research density for its size: life sciences and genomics, semiconductor and processor IP, engineering biology and AI, with a mature spin-out culture and specialist investors who understand long timelines.	Four research-intensive universities, the deepest venture and growth capital pool in Europe, financial regulators, the largest concentration of applied AI companies in the UK and a global-scale creative production economy — all within one travel-to-work area.	Advanced materials research including graphene and 2D materials, a large health innovation base built on hospitals and universities, a substantial digital and cyber economy, and the biggest broadcast and creative cluster outside London.
What's missing · UKIZ interpretation	Ownership retention. Discovery and early company formation work; the Series B onward stage frequently transfers ownership overseas. Laboratory and scale-up space, power and housing also constrain growth.	Circulation. Capital, talent and corporate demand concentrate in London rather than flowing outward, so capability elsewhere in Britain competes for attention with opportunities on the investor's doorstep. Cost also pushes production and scale-up activity out without a route back in.	The step from materials discovery to volume production, and a growth capital base proportionate to the research output. Health data at population scale is under-used by industry.
What could connect · UKIZ interpretation	Cambridge discovery connected to UK manufacturing and biomanufacturing capacity, and to later-stage domestic capital, so that value created here is realised here rather than acquired out of the country.	London as the demand and capital node of a national network: investors, corporate buyers and regulators deliberately connected to complementary manufacturing, materials and energy capability in the North, Midlands, Scotland and Wales.	Materials research connected to Sheffield and Midlands manufacturing, and health innovation connected to Leeds health data capability — a corridor rather than three separate cities.
UKIZ relevance	Cambridge produces intellectual property at a rate few places match, and loses ownership of too much of it at Series B. The proposed Oxford–Cambridge zone concentrates on commercialisation and retention rather than on more discovery.	London's problem is not capability, it is direction of travel: capital and talent gravitate here rather than circulating. The proposed London zone focuses on using that density to fund and buy from capability elsewhere in Britain.	Manchester has scale in four different economies that rarely commission from each other. The proposed zone concentrates on connecting health, materials, digital and creative capability around shared missions.
Last verified	15 August 2026	15 August 2026	15 August 2026

Proposed by UKIZ · not a government designation

Back to the map →Methodology →